Dawnrays Pharmaceutical (Holdings) Limited's Board resolved to declare an interim dividend of HKD 0.015 per share for the year ending 31 December 2023, approximately amounting to a total sum of HKD 22,497,000 (equivalent to approximately RMB 20,986,000). The register of members of the company will be closed from 21 September 2023 to 22 September 2023 (both days inclusive), for the purpose of ascertaining entitlement to the company's interim dividend, during which period no transfer of shares will be registered. The record date for the purpose of determining shareholders' entitlement to the interim dividend is 22 September 2023.

Dividend warrants will be dispatched to shareholders on or about 5 October 2023.